On March 28th, a sub-forum on the pharmaceutical and healthcare industry was held as part of the 2018 Guangzhou Annual Investment Conference, aiming to outline the latest progress and emerging opportunities in the industry.

During the forum, a number of overseas representatives gave presentations pitching their busines and expressing willingness to cooperate with local enterprises.

Kalim Mir, Founder of XGenomes, spoke on how his company has invented a DNA sequencing technology which could facilitate precision medicine with lower costs and higher efficiency. “I hope Chinese pharmaceutical companies could invest more in new technology around the world, so that we may further development,” he said.

In addition, GPHL also demonstrates its Wanglaoji’s TCM bar-code system during the investment conference. The system enables traditional Chinese medicine to be identified via DNA technology, and has gained a prestigious national science award.

Wanglaoji’s TCM bar-code system is displayed at the 2018 Guangzhou Annual Investment Conference.[Photo\Newsgd.com]

Chen Mao, General Manager of GPHL, said an enterprise could not develop without cooperation with its industrial counterparts. “In this sense (of mutual cooperation), the pharmaceutical and healthcare forum gathers international talent and resources to map out how best to boost industrial development,” said Chen.